NO954495L - Kim-linje-mutasjoner i det MTS-gen og fremgangsmåte for påvisning av disposisjon for kreft ved MTS-genet - Google Patents

Kim-linje-mutasjoner i det MTS-gen og fremgangsmåte for påvisning av disposisjon for kreft ved MTS-genet

Info

Publication number
NO954495L
NO954495L NO954495A NO954495A NO954495L NO 954495 L NO954495 L NO 954495L NO 954495 A NO954495 A NO 954495A NO 954495 A NO954495 A NO 954495A NO 954495 L NO954495 L NO 954495L
Authority
NO
Norway
Prior art keywords
mts gene
predisposition
germ
cancer
detecting
Prior art date
Application number
NO954495A
Other languages
English (en)
Norwegian (no)
Other versions
NO954495D0 (no
Inventor
Mark H Skolnick
Lisa A Cannon-Albright
Alexander Kamb
Original Assignee
Univ Utah Res Found
Myriad Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27539687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO954495(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Utah Res Found, Myriad Genetics Inc filed Critical Univ Utah Res Found
Publication of NO954495D0 publication Critical patent/NO954495D0/no
Publication of NO954495L publication Critical patent/NO954495L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO954495A 1994-03-18 1995-11-08 Kim-linje-mutasjoner i det MTS-gen og fremgangsmåte for påvisning av disposisjon for kreft ved MTS-genet NO954495L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21508794A 1994-03-18 1994-03-18
US21458294A 1994-03-18 1994-03-18
US21508694A 1994-03-18 1994-03-18
US22736994A 1994-04-14 1994-04-14
US25193894A 1994-06-01 1994-06-01
PCT/US1995/003537 WO1995025813A1 (fr) 1994-03-18 1995-03-17 Mutations de lignees germinales dans le gene mts et procede permettant de detecter une predisposition au cancer dans le gene mts

Publications (2)

Publication Number Publication Date
NO954495D0 NO954495D0 (no) 1995-11-08
NO954495L true NO954495L (no) 1996-01-17

Family

ID=27539687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954495A NO954495L (no) 1994-03-18 1995-11-08 Kim-linje-mutasjoner i det MTS-gen og fremgangsmåte for påvisning av disposisjon for kreft ved MTS-genet

Country Status (11)

Country Link
US (9) US5624819A (fr)
EP (1) EP0702730A4 (fr)
JP (1) JPH08510391A (fr)
CN (1) CN1128049A (fr)
AU (1) AU685627B2 (fr)
CA (1) CA2162150C (fr)
FI (1) FI955416A (fr)
NO (1) NO954495L (fr)
NZ (1) NZ284612A (fr)
RU (1) RU2161309C2 (fr)
WO (1) WO1995025813A1 (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962316A (en) * 1992-10-16 1999-10-05 Cold Spring Harbor Laboratory Cell-cycle regulatory proteins, and uses related thereto
US7691632B2 (en) * 1993-11-18 2010-04-06 Cold Spring Harbor Laboratory Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression
WO1995019369A1 (fr) 1994-01-14 1995-07-20 Vanderbilt University Procede de detection et de traitement du cancer du sein
CA2162150C (fr) * 1994-03-18 2010-03-30 Mark H. Skolnick Mutations de lignees germinales dans le gene mts et procede permettant de detecter une predisposition au cancer dans le gene mts
US6060301A (en) * 1994-03-18 2000-05-09 Myriad Genetics, Inc. Vector containing MTS1E1β gene
US6689864B1 (en) 1994-04-14 2004-02-10 The Regents Of The University Of California Cyclin dependent kinase 4 inhibitor
US5767258A (en) * 1995-05-12 1998-06-16 The Johns Hopkins University School Of Medicine Cell cycle regulatory gene
US7163925B1 (en) 1995-07-17 2007-01-16 Board Of Regents, The University Of Texas System p16 expression constructs and their application in cancer therapy
HUP9901908A3 (en) 1995-07-17 2000-02-28 Univ Texas P16 expression constructs and their application in cancer therapy
GB9519275D0 (en) 1995-09-21 1995-11-22 Univ Dundee Substances and their therapeutic use
US5723313A (en) * 1995-09-27 1998-03-03 St. Jude Children's Research Hospital ARF-p19, a novel regulator of the mammalian cell cycle
US6407062B1 (en) 1995-09-27 2002-06-18 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US6586203B1 (en) 1995-09-27 2003-07-01 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US5891857A (en) * 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US5952178A (en) * 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
CN1181422A (zh) * 1996-10-31 1998-05-13 上海市肿瘤研究所 与生长因子受体结合的多肽所构建的基因转移载体
GEP20032896B (en) 1997-10-27 2003-02-25 Agouron Pharma 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
US6177410B1 (en) 1997-12-05 2001-01-23 Vanderbilt University Therapeutic methods for prostate cancer
US6897018B1 (en) * 1998-02-25 2005-05-24 The United States Of America As Represented By The Department Of Health And Human Services DLC-1 gene deleted in cancers
WO1999045021A1 (fr) * 1998-03-03 1999-09-10 Affymetrix, Inc. Genes regules par le cycle cellulaire
US6183958B1 (en) * 1998-05-06 2001-02-06 Variagenics, Inc. Probes for variance detection
US6225456B1 (en) 1998-05-07 2001-05-01 University Technololy Corporation Ras suppressor SUR-5
US6489305B1 (en) * 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
US6506889B1 (en) 1998-05-19 2003-01-14 University Technology Corporation Ras suppressor SUR-8 and related compositions and methods
US6576420B1 (en) * 1998-06-23 2003-06-10 Regents Of The University Of California Method for early diagnosis of, and determination of prognosis in, cancer
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US7306926B2 (en) * 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
KR20000038917A (ko) * 1998-12-10 2000-07-05 성재갑 곤충세포를 이용한 cdk6/p16 복합체의 제조방법
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
US6174681B1 (en) * 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer
EP2325321A1 (fr) * 1999-05-28 2011-05-25 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Vecteur du virus de la vaccine combinant délétion du facteur de croissance et délétion de thymidine kinase
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
AU2001264934A1 (en) 2000-05-23 2001-12-03 The University Of Texas System Dna repair polypeptides and methods of use
ATE375404T1 (de) * 2000-06-27 2007-10-15 Von Recklinghausen Ges E V Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose
US7906492B2 (en) * 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
NZ536548A (en) * 2002-04-16 2007-11-30 Dana Farber Cancer Inst Inc Using stem cells to make chimeric non-human animals having tumors or the ability to develop tumors
US6909444B2 (en) * 2002-09-09 2005-06-21 Dai Nippon Printing Co., Ltd. Transfer ribbon, image expressing medium and method for production of them
WO2004113502A2 (fr) * 2003-06-20 2004-12-29 Avalon Pharmaceuticals, Inc. Identification d'agents therapeutiques par la technique des empreintes genetiques
ATE289685T1 (de) * 2003-08-25 2005-03-15 Mtm Lab Ag Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
US20050075543A1 (en) * 2003-10-03 2005-04-07 Calabrese Charles A. Method of anonymous medical testing and providing the patient with the test results
WO2005051971A1 (fr) * 2003-11-24 2005-06-09 Canji, Inc. Réduction de cicatrisation dermique
CA2576159A1 (fr) * 2004-08-27 2006-03-02 Cyclacel Limited Methode de traitement et compositions
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
US8323644B2 (en) * 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US20090053221A1 (en) * 2006-01-17 2009-02-26 Cheung Nai-Kong V Immune response enhancing glucan
RU2511408C2 (ru) * 2007-09-17 2014-04-10 Конинклейке Филипс Электроникс Н.В. Способ анализа нарушений, связанных с раком яичников
WO2009077642A1 (fr) * 2007-12-19 2009-06-25 University Of Helsinki Procédé de criblage
WO2010068850A1 (fr) * 2008-12-12 2010-06-17 Georgetown University Procédés de diagnostic et de traitement du cancer
US8715937B2 (en) 2010-11-15 2014-05-06 Exact Sciences Corporation Mutation detection assay
RU2484096C1 (ru) * 2012-02-08 2013-06-10 Общество с ограниченной ответственностью "Технофарма" ОДНОДОМЕННОЕ АНТИТЕЛО, СПЕЦИФИЧЕСКИ СВЯЗЫВАЮЩЕЕ БЕЛОК S100A4/Mts1, ПРИМЕНЕНИЕ ПОЛУЧЕННОГО АНТИТЕЛА ДЛЯ ДЕТЕКЦИИ ЭТОГО БЕЛКА
CN103127528B (zh) * 2012-09-14 2016-04-20 苏州大学 人类dcx基因在制备胶质瘤放疗增敏剂中的应用
CN106701920A (zh) * 2016-11-25 2017-05-24 苏州首度基因科技有限责任公司 一种预测结直肠癌肝转移的试剂盒和使用方法
RU2694231C1 (ru) * 2018-01-09 2019-07-10 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Башкирский Государственный Педагогический Университет Им. М. Акмуллы" Способ определения предрасположенности к онкопатологии

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801038A (en) * 1984-05-29 1998-09-01 Genencor International Inc. Modified subtilisins having amino acid alterations
EP0566571B1 (fr) * 1990-07-09 1997-05-07 Research Corporation Technologies, Inc. Diagnostic du cancer a l'etat de metastases a l'aide du gene mts-1
US5889169A (en) * 1991-05-16 1999-03-30 Cold Spring Harbor Laboratory Cell cycle regulatory protein p16 gene
WO1994009135A1 (fr) * 1992-10-16 1994-04-28 Cold Spring Harbor Laboratory Reagencement de complexes de cyclines et leurs utilisations
US6211334B1 (en) * 1992-10-16 2001-04-03 Cold Spring Harbor Cell-cycle regulatory proteins, and uses related thereto
US5962316A (en) * 1992-10-16 1999-10-05 Cold Spring Harbor Laboratory Cell-cycle regulatory proteins, and uses related thereto
US6043030A (en) * 1992-12-17 2000-03-28 Cold Spring Harbor Laboratory Cell-cycle regulatory proteins, and uses related thereto
US5919997A (en) * 1993-11-18 1999-07-06 Cold Spring Habor Labortary Transgenic mice having modified cell-cycle regulation
CA2162150C (fr) * 1994-03-18 2010-03-30 Mark H. Skolnick Mutations de lignees germinales dans le gene mts et procede permettant de detecter une predisposition au cancer dans le gene mts
US6689561B1 (en) * 1994-04-14 2004-02-10 The Regents Of The University Of California Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
US6033847A (en) * 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof

Also Published As

Publication number Publication date
JPH08510391A (ja) 1996-11-05
RU2161309C2 (ru) 2000-12-27
CN1128049A (zh) 1996-07-31
US6180776B1 (en) 2001-01-30
EP0702730A1 (fr) 1996-03-27
US5624819A (en) 1997-04-29
WO1995025813A1 (fr) 1995-09-28
FI955416A0 (fi) 1995-11-10
EP0702730A4 (fr) 1997-05-07
FI955416A (fi) 1996-01-09
US5739027A (en) 1998-04-14
CA2162150C (fr) 2010-03-30
NO954495D0 (no) 1995-11-08
US6037462A (en) 2000-03-14
CA2162150A1 (fr) 1995-09-28
AU685627B2 (en) 1998-01-22
NZ284612A (en) 1997-09-22
US6090578A (en) 2000-07-18
AU2378995A (en) 1995-10-09
US6218146B1 (en) 2001-04-17
US5994095A (en) 1999-11-30
US5801236A (en) 1998-09-01
US6140473A (en) 2000-10-31

Similar Documents

Publication Publication Date Title
NO954495L (no) Kim-linje-mutasjoner i det MTS-gen og fremgangsmåte for påvisning av disposisjon for kreft ved MTS-genet
NO970320L (no) System for bruk ved brönn-komplettering
HUP9901856A3 (en) Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
DE9416270U1 (de) Laborprobenbehälter
GB9110500D0 (en) Slab electrophoresis system with improved sample wells and cooling mechanism
FI951801A0 (fi) CTLA4-molekyylit ja IL4:sitovat molekyylit sekä näiden käyttö
KR970004976A (ko) 플라즈마의 검침을 위한 샘플러
IL121483A (en) Remote-dosing analyte concentration meter
FI102476B (fi) Uudet siirtymämetallikompleksit ja menetelmä niiden valmistamiseksi
NO972003D0 (no) Fremgangsmåte for bestemmelse av selv-diffusjonsegenskaper
DE69515643D1 (de) Fühlerprobe
EP1060263A4 (fr) Technique et composition permettant une detection de la luciferase dans des echantillons biologiques
FI955415A0 (fi) MTS-geeni, sen mutaatiot ja menetelmät syövän toteamiseksi MTS-geenisekvenssejä käyttäen
GB9511752D0 (en) Protein biosensor and method for protein measurement
DE59707845D1 (de) Kryostatmikrotom
FI940225A (fi) Menetelmä näytteessä olevan metallin määrittämiseksi
AU8480298A (en) Apparatus and process for measuring absorbance in fluid samples
GB2301443B (en) Apparatus for measuring angles for mitres and bevels
FI981428A0 (fi) Referenssiaine käytettäväksi levosimendaanierien analyysissä
DE19581529T1 (de) On-Line Strichcode Überprüfungssystem
FI954344A0 (fi) Menetelmä näytteessä olevan metallin määrittämiseksi
EP0598460A3 (fr) Procédé d'analyse de substance et cellule de mesure pour l'application du procédé.
FI982669A0 (fi) Järjestelmä ja menetelmä analyysin otpimoimiseksi
KR960005892U (ko) 수평 및 각도측정이 용이한 수준기
SE9401527D0 (sv) Method of detecting cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application